Metformin extended release for the treatment of Type 2 diabetes mellitus

Author： Schwartz Sherwyn L   Wu Jacqueline F   Berner Bret  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.6, 2006-04, pp. : 803-809

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical development of metformin extended-release tablets for type 2 diabetes: an overview

By Schwartz Sherwin L   Gordi Toufigh   Hou Eddie   Cramer Marilou   Heritier Michelle   Cowles Verne E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1235-1243

Informa Healthcare

Access to resources Recommend Favorite

Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth Mary   Stein Stephanie Aleskow   Davis Stephen N  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2545-2554

Informa Healthcare

Access to resources Recommend Favorite

Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus

By Scott Lesley J.  

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1679-1707

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

By Erhardt Wilma  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 189-202

Adis International

Access to resources Recommend Favorite

Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus

By Jaime A. Davidson  

Drug Safety, Vol. 27, Iss. 15, 2004-01 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite